AURIZON
Country: Велика Британија
Језик: Енглески
Извор: HMA (Heads of Medicines Agencies)
Карактеристике производа
(SPC)
05-01-2012
Неки документи за овај производ тренутно нису доступни, можете послати захтев нашој служби за кориснике и ми ћемо вас обавестити чим их будемо могли добити.
Пошаљите упит.
Пошаљите упит.
Активни састојак:
clotrimazole 10 mg/ml, dexamethasone acetate 1 mg/ml, marbofloxacin 3 mg/ml
Доступно од:
Vetoquinol
АТЦ код:
QS02CA06
Фармацеутски облик:
Ear drops, suspension
Терапеутска група:
dexamethasone and antiinfectives
Терапеутска област:
Dogs
Датум одобрења:
2010-11-09
Карактеристике производа
VETOQUINOL/AURI ZON/EUROPEAN RENEWAL/JUNE 2010
1/10
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
AURIZON ear drops, suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ML OF AURIZON CONTAINS:
ACTIVE SUBSTANCES:
Marbofloxacin ............................................................... 3.0 mg
Clotrimazole ............................................................... 10.0 mg
Dexamethasone acetat e................................................ 1.0 mg
( equivalent to dexamethasone .................................... 0.9 mg)
EXCIPIENTS
Propyl galate (E310)……………………………………… 1.0 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Ear drops, suspension
Homogenous beige to yellow oily suspension
4.
CLINICAL PARTICULARS
4.1. TARGET SPECIES
Dogs
4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
-
Treatment of otitis externa of both bacterial_ _and_ _fungal origin - respectively due to bacteria
sensitive to marbofloxacin, and fungi especially _Malassezia pachydermatis _sensitive to
clotrimazole.
The product should be used based on susceptibility testing.
4.3. CONTRAINDICATIONS
Do not administer to dogs suffering from perforation of the tympanic membrane. Do not administer to
dogs with known hypersensitivity to any of the ingredients.
Do not administer to pregnant or lactating bitches.
4.4. SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
VETOQUINOL/AURI ZON/EUROPEAN RENEWAL/JUNE 2010
2/10
4.5. Special precautions for use
I) SPECIAL PRECAUTIONS FOR
Прочитајте комплетан документ
